153 related articles for article (PubMed ID: 1897341)
1. Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine.
Fletcher JE; Conti PA; Rosenberg H
Acta Anaesthesiol Scand; 1991 Aug; 35(6):483-7. PubMed ID: 1897341
[TBL] [Abstract][Full Text] [Related]
2. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J
Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
[TBL] [Abstract][Full Text] [Related]
3. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H
Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135
[TBL] [Abstract][Full Text] [Related]
4. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
6. Comparison of European and North American malignant hyperthermia diagnostic protocol outcomes for use in genetic studies.
Fletcher JE; Rosenberg H; Aggarwal M
Anesthesiology; 1999 Mar; 90(3):654-61. PubMed ID: 10078664
[TBL] [Abstract][Full Text] [Related]
7. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
8. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
[TBL] [Abstract][Full Text] [Related]
9. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
10. Porcine malignant hyperthermia: false negatives in the halothane test.
Gallant EM; Rempel WE
Am J Vet Res; 1987 Mar; 48(3):488-91. PubMed ID: 3565905
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Hopkins PM; Ellis FR; Halsall PJ
Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
13. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
[TBL] [Abstract][Full Text] [Related]
14. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Urwyler A; Censier K; Kaufmann MA; Drewe J
Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs.
Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F
Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility.
Baur CP; Bellon L; Felleiter P; Fiege M; Fricker R; Glahn K; Heffron JJ; Herrmann-Frank A; Jurkat-Rott K; Klingler W; Lehane M; Ording H; Tegazzin V; Wappler F; Georgieff M; Lehmann-Horn F
Anesth Analg; 2000 Jan; 90(1):200-5. PubMed ID: 10625004
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
Allen GC; Larach MG; Kunselman AR
Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
[TBL] [Abstract][Full Text] [Related]
18. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
[TBL] [Abstract][Full Text] [Related]
19. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
Ellis FR; Halsall PJ; Hopkins PM
Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.
Islander G; Twetman ER
Anesth Analg; 1999 May; 88(5):1155-60. PubMed ID: 10320187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]